SIC 2833 – Medicinal Chemicals and Botanical Products
| Valuation | |
|---|---|
| Market Cap ($M) | 28.08 |
| Enterprise Value ($M) | 32.48 |
| Book Value ($M) | 80.19 |
| Book Value / Share | 12.94 |
| Price / Book | 0.35 |
| NCAV ($M) | -18.60 |
| NCAV / Share | -3.00 |
| Price / NCAV | -1.51 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.06 |
| Return on Assets (ROA) | -0.05 |
| Return on Equity (ROE) | -0.10 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.50 |
| Current Ratio | 2.56 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 62.48 |
| Assets | 161.27 |
| Liabilities | 81.08 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 113.80 |
| Operating Income | -8.53 |
| Net Income | -7.22 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -1.50 |
| Cash from Investing | -3.02 |
| Cash from Financing | 2.89 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Renaissance Technologies Llc | 5.55 | -9.75 | |
| 13G/A | Dimensional Fund Advisors Lp | 7.20 | -14.12 | |
| 13G/A | Caldwell Securities, Inc | 7.40 | -3.43 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 127 | 4,643 | 2.74 | |
| 416 | 3,370 | 12.34 | |
| 895 | 4,712 | 18.99 | |
| 321 | 4,820 | 6.66 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| MRNS – Marinus Pharmaceuticals, Inc. | MRUS – Merus N.V. |
| MURA – Mural Oncology plc | NAMS – NewAmsterdam Pharma Company N.V. |
| NGNE – Neurogene Inc. |
Financial data and stock pages provided by
Fintel.io